C07D 495/10
Spiro-condensed systems
C07D495/10 (Spiro-condensed systems) appears on 569 US grants and 511 published applications in this corpus.
Search patents in C07D- Granted patents
- 569
- Published applications
- 511
- Assignees
- 284
- Inventors
- 2,121
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 3 | 0 |
| 1978 | 8 | 0 |
| 1979 | 2 | 0 |
| 1980 | 6 | 0 |
| 1981 | 7 | 0 |
| 1982 | 6 | 0 |
| 1983 | 5 | 0 |
| 1984 | 3 | 0 |
| 1985 | 4 | 0 |
| 1986 | 4 | 0 |
| 1987 | 7 | 0 |
| 1988 | 8 | 0 |
| 1989 | 10 | 0 |
| 1990 | 9 | 0 |
| 1991 | 10 | 0 |
| 1992 | 12 | 0 |
| 1993 | 14 | 0 |
| 1994 | 2 | 0 |
| 1995 | 6 | 0 |
| 1996 | 6 | 0 |
| 1997 | 12 | 0 |
| 1998 | 12 | 0 |
| 1999 | 9 | 0 |
| 2000 | 14 | 0 |
| 2001 | 18 | 1 |
| 2002 | 18 | 9 |
| 2003 | 8 | 8 |
| 2004 | 6 | 13 |
| 2005 | 5 | 16 |
| 2006 | 3 | 15 |
| 2007 | 7 | 14 |
| 2008 | 9 | 9 |
| 2009 | 8 | 16 |
| 2010 | 21 | 25 |
| 2011 | 15 | 14 |
| 2012 | 12 | 16 |
| 2013 | 14 | 16 |
| 2014 | 20 | 19 |
| 2015 | 16 | 27 |
| 2016 | 16 | 30 |
| 2017 | 20 | 19 |
| 2018 | 16 | 22 |
| 2019 | 40 | 35 |
| 2020 | 18 | 28 |
| 2021 | 14 | 21 |
| 2022 | 19 | 35 |
| 2023 | 11 | 21 |
| 2024 | 25 | 26 |
| 2025 | 22 | 30 |
| 2026 | 9 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Fluorescent ion indicators and their applications29 Sep 2026US 12,748,118 B2AAT Bioquest, Inc.
- N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides8 Sep 2026US 12,729,196 B2AstraZeneca AB
- Organic electroluminescence device and polycyclic compound for organic electroluminescence device25 Aug 2026US 12,721,037 B2Samsung Display Co., Ltd.
- EGFR inhibitors23 Jun 2026US 12,662,465 B2Blueprint Medicines Corporation
- Heteroaryl compounds as inhibitors of programmed necrosis pathway, composition and method using the same28 Apr 2026US 12,612,413 B2Accro Bioscience (HK) Limited
- Compound containing oxo-pyrido-aliphatic ring or aliphatic heterocyclic structure, and medical use thereof8 Oct 2026US 2026/0308164 A1Sichuan Purity Pharmaceutical Co., Ltd.
- Sulfoximine compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same1 Oct 2026US 2026/0297073 A1Chong Kun Dang Pharmaceutical Corp.
- Oxazole trpml1 agonists and uses thereof1 Oct 2026US 2026/0297104 A1Libra Therapeutics, Inc.
- Compounds as sumo activating enzyme inhibitors1 Oct 2026US 2026/0297109 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Most cited
By later US patents
- Phosphinylalkanoyl substituted prolines156US 4,337,201 AE. R. Squibb & Sons, Inc. · 1982
- Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake111US 5,994,391 AG. D. Searle & Co. · 1999
- Compounds having effects on serotonin-related systems87US 5,741,789 AEli Lilly and Company · 1998
- Polychromic tetracyclo-spiro-adamatylidene derivatives, and polychromic lens incorporating said compounds84US 4,685,783 APlessey Incorporated · 1987
- Alkoxy-alkyl-substituted 1H-3-aryl-pyrrolidine-2, 4-diones used as herbicicides and pesticides84US 5,830,826 ABayer Aktiengesellschaft · 1998